Scientific Advisory Board Member Interview – Ashok Srivastava, M.D./Ph.D.
Saturday, February 3, 2024 1 min read
Key Takeaway: The article features an interview with Dr. Ashok Srivastava, a member of the Scientific Advisory Board at Calidi Biotherapeutics. It emphasizes his contributions and insights into the field of biotherapeutics. This interview is part of a series highlighting the expertise of advisory board members.
Price reaction · baseline $95.988 (2024-02-02 close) · hit after-hours · clean, no other CLDI news in the window
day 0 close
-6.3%
day 1
-2.9%
day 3 · peak
-26%
Market Sentiment Analysis
POSITIVE FACTORS
Interview highlights expertise of Dr. Ashok Srivastava.
Focus on advancements in biotherapeutics.
Strengthens Calidi Biotherapeutics' advisory team.
Full Press Release Details
Scientific Advisory Board Member Interview – Ashok Srivastava, M.D./Ph.D. Interviews & Media February 3, 2024 Next Post Scientific Advisory Board Member Interview – Bernard Fox, Ph.D. Previous Post Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board
Frequently Asked Questions
Who is Dr. Ashok Srivastava?
Dr. Ashok Srivastava is a member of the Scientific Advisory Board at Calidi Biotherapeutics.
What is the focus of the interview?
The interview focuses on Dr. Srivastava's expertise and insights in biotherapeutics.
What company is Dr. Srivastava associated with?
Dr. Srivastava is associated with Calidi Biotherapeutics.
What type of content is featured in the article?
The article features an interview with Dr. Srivastava discussing his contributions.